US323 — Cincinnati, Ohio

US323 is a clinical research site located in Cincinnati, Ohio, United States.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

US323 has participated in 2 clinical trials.

Therapeutic areas: Alzheimer's Disease.

Sponsors: H. Lundbeck A/S.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cincinnati

Browse all research sites in Ohio · View every site in Cincinnati

• The Jewish Hospital - Mercy
• The Linder Center for Education and Research at The Christ Hospital
• University of Cincinnati Health Center
• Good Samaritan Hospital Cancer Treatment Center, Hatton Institute
• Veterans Administration Hospital of Cincinnati
• The Lindner Research Center at Christ Hospital
• Cincinnati Children's Hospital Medical Center Liberty Campus
• University of Cincinnati Cancer Center CTO
• University of Cincinnati Mayfield Clinic and Spine Institute
• University of Cincinnati Health Barrett Cancer Center
• Deaconess Hospital
• Veterans Administration Medical Center - Cincinnati

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US323?

US323 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US323 conducted?

US323 has 2 clinical trials on record. Their work covers Alzheimer's Disease.

Is US323 accredited by Crixeo Clinical Trials?

US323 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US323?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.